Autism Spectrum Disorder: Mitochondrial Dysfunction, Gut Dysbiosis, and the Metabolic Overlap

The physiology

Autism spectrum disorder involves multiple intersecting biological abnormalities, among which mitochondrial dysfunction and gut-brain axis disruption have attracted the strongest metabolic research interest. Mitochondrial dysfunction — impaired oxidative phosphorylation and elevated reactive oxygen species — is documented in a significant subset of ASD individuals, particularly those with regression (loss of previously acquired skills). The gut microbiome in ASD is consistently dysbiotic: reduced diversity, elevated LPS-producing bacteria, and increased intestinal permeability allow bacterial endotoxins to reach the systemic circulation, driving neuroinflammation through microglia activation.

"I didn't know that I had autism."

The ketogenic diet addresses both mechanisms: it reduces the carbohydrate substrate that drives the dysbiotic bacteria, improves gut barrier integrity, reduces neuroinflammation, and — critically — provides an alternative fuel for mitochondria that bypasses the specific complex I defects documented in ASD mitochondrial research. Multiple animal model studies and a growing number of clinical reports document behavioural improvement on ketogenic diets in ASD. The Paleomedicina group has published case series of children with ASD and epilepsy achieving substantial improvement in both conditions simultaneously on a ketogenic protocol.

Five stories

Leo — ASD with regression

Leo, 6, had developed normally until 18 months, then regressed — losing language and social skills he had previously acquired. His parents sought metabolic evaluation after reading research on mitochondrial dysfunction in ASD regression. His assessment revealed elevated lactate, a marker of mitochondrial impairment. A ketogenic diet was implemented by a specialist paediatric team. Over eight months, Leo regained some language and showed improvements in social eye contact that had been absent since the regression. His team regards him as a mitochondrial ASD case in which the metabolic intervention reached the underlying pathology.

Mara — High-functioning ASD and anxiety

Mara, 24, received her ASD diagnosis as an adult — a high-masking woman whose autism had been missed through school and university. She had severe comorbid anxiety and gastrointestinal symptoms. Her gut microbiome analysis showed severe dysbiosis. A low-carbohydrate, eventually ketogenic diet resolved her gastrointestinal symptoms within six weeks. Her anxiety reduced proportionally — consistent with the gut-brain axis model in which gut-derived inflammatory signals prime the fear circuit. She continues to have ASD but describes her quality of life as transformed by addressing the metabolic comorbidities.

Jamie — Non-verbal ASD, GFCF to ketogenic

Jamie, 8, was non-verbal with ASD and severe behavioural dysregulation — meltdowns lasting hours, self-injurious behaviour, and minimal social responsiveness. His parents had implemented a gluten-free casein-free diet that produced partial improvement. A specialist team transitioned him to a ketogenic diet to address the neuroinflammation that GFCF had not fully resolved. Within six months his behavioural dysregulation had reduced significantly. He remains non-verbal but the reduction in apparent distress and the increase in initiating social interaction have been marked by both his family and his school.

Kenji — ASD with epilepsy

Kenji, 10, had ASD and drug-resistant epilepsy — a common co-occurrence consistent with shared GABA/glutamate dysregulation. His epilepsy team introduced a ketogenic diet primarily for seizure control. Seizures reduced by 70%; simultaneously and unexpectedly, his teachers reported improvement in attention, communication, and flexibility. His ASD team, reviewing the case, concluded the metabolic intervention had addressed both conditions through shared neurochemical pathways — a finding consistent with the literature on ketogenic diet in ASD-epilepsy comorbidity.

Sage — Late-diagnosed adult ASD with metabolic syndrome

Sage, 38, received an ASD diagnosis at 35 after decades of misidentification as anxiety and ADHD. They had metabolic syndrome — insulin resistance, obesity, elevated inflammatory markers — which their metabolic psychiatrist argued was driving their severe sensory hypersensitivity and emotional dysregulation through chronic neuroinflammation. A ketogenic diet reversed the metabolic syndrome over eight months. Sage describes the change in sensory experience as the world becoming quieter — not the underlying ASD changed, but the inflammatory amplification of sensory input reduced.